No Data
No Data
No Data
No Data
No Data
Express News | Wedbush Reiterates Outperform on Prime Medicine, Maintains $12 Price Target
Moomoo 24/713:14 ET
Express News | Prime Medicine Shares Are Trading Higher After the Company Announced That It Will Present Preclinical Data Highlighting the Broad Potential of Its Prime Editing Technology and Supporting the Advancement of Its Programs at Upcoming Scientific Meetings
Moomoo 24/7Apr 23 10:54 ET
Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings
PDF Version -- Presentations include new preclinical data for PM359, further demonstrating ability of Prime Editors to efficiently, reproducibly and durably correct causative mutation of CGD; on
Prime MedicineApr 23 00:00 ET
Prime Medicine Initiated at Buy by Chardan Capital
Prime Medicine Initiated at Buy by Chardan Capital
Dow JonesApr 22 08:00 ET
Buy Rating Affirmed for Prime Medicine, Inc. on Groundbreaking Genetic Editing Platform and Strategic Progress
TipRanksApr 22 07:55 ET
Express News | Prime Medicine Inc : Chardan Capital Markets Initiates Coverage With Buy Rating; Target Price $17
Moomoo 24/7Apr 22 07:49 ET
Mafiosa818 : im watching
No Data
No Data